Skip to main navigation Skip to search Skip to main content

ASXL1 mutation is a novel risk factor for bleeding in Philadelphia-negative myeloproliferative neoplasms

  • Hassan Awada
  • , Manasa Bhatta
  • , Han Yu
  • , Wenyan Ji
  • , Surui Hou
  • , Tara Cronin
  • , Sheeba Ba Aqeel
  • , Arya Mariam Roy
  • , Muhammad Salman Faisal
  • , Peter Kouides
  • , John Mascarenhas
  • , Elizabeth A. Griffiths
  • , Amro Elshoury
  • Roswell Park Cancer Institute
  • Icahn School of Medicine at Mount Sinai
  • Virginia Polytechnic Institute and State University
  • Rochester General Hospital
  • Cancer Care of Western New York

Research output: Contribution to journal › Article › peer-review

7 Scopus citations
Original languageEnglish
JournalLeukemia
DOIs
StateAccepted/In press - 2023

Fingerprint

Dive into the research topics of 'ASXL1 mutation is a novel risk factor for bleeding in Philadelphia-negative myeloproliferative neoplasms'. Together they form a unique fingerprint.

Cite this